Skip to main content
. 2006 Apr 21;62(3):280–287. doi: 10.1111/j.1365-2125.2006.02658.x

Table 6.

Numbers of clinically significant decreases in ambulatory blood pressure (BP)

Number of subjects with a CSD in ambulatory BP
Group A B C
SBP Screening  1 (9)  1 (2)  3 (6)
Tadalafil 29 (170) 33 (310) 28 (130)
Placebo 27 (96) 28 (153) 25 (90)
DBP Screening  2 (4)  1 (3)  7 (17)
Tadalafil 35 (195) 35 (273) 37 (162)
Placebo 31 (175) 29 (152) 32 (120)

CSD, Clinically significant decrease; (number of clinically significant decreases); SBP, systolic blood pressure; DBP diastolic blood pressure.